| 1 |
34923175 | Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats. | 2022 |
1 |
| 2 |
35150894 | Attenuation of obesity-induced hyperlipidemia reduces tumor growth. | 2022 Apr |
2 |
| 3 |
35220605 | Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles. | 2022 Feb 26 |
1 |
| 4 |
35524581 | Hepatic MDM2 Causes Metabolic Associated Fatty Liver Disease by Blocking Triglyceride-VLDL Secretion via ApoB Degradation. | 2022 May 7 |
2 |
| 5 |
31221535 | Plasma glucose, triglycerides, VLDL, leptin and resistin levels as potential biomarkers for myocardial fat in mice. | 2020 Jan - Feb |
1 |
| 6 |
32226531 | Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis. | 2020 |
2 |
| 7 |
33042259 | Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development. | 2020 |
1 |
| 8 |
30516845 | Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis. | 2019 Aug |
4 |
| 9 |
31002535 | Myonectin deletion promotes adipose fat storage and reduces liver steatosis. | 2019 Jul |
1 |
| 10 |
29259130 | Cathepsin B regulates hepatic lipid metabolism by cleaving liver fatty acid-binding protein. | 2018 Feb 9 |
1 |
| 11 |
29700117 | Sterol carrier protein-2 deficiency attenuates diet-induced dyslipidemia and atherosclerosis in mice. | 2018 Jun 15 |
1 |
| 12 |
30385734 | Dietary protein restriction reduces circulating VLDL triglyceride levels via CREBH-APOA5-dependent and -independent mechanisms. | 2018 Nov 2 |
4 |
| 13 |
28431321 | Atherogenicity of amino acids in the lipid-laden macrophage model system in vitro and in atherosclerotic mice: a key role for triglyceride metabolism. | 2017 Jul |
1 |
| 14 |
28694219 | Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion. | 2017 Oct |
1 |
| 15 |
29074588 | GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance. | 2017 Dec |
1 |
| 16 |
27655915 | Very Low Density Lipoprotein Assembly Is Required for cAMP-responsive Element-binding Protein H Processing and Hepatic Apolipoprotein A-IV Expression. | 2016 Nov 4 |
3 |
| 17 |
25457203 | S-Adenosylmethionine increases circulating very-low density lipoprotein clearance in non-alcoholic fatty liver disease. | 2015 Mar |
6 |
| 18 |
25954050 | Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion. | 2015 Jul |
1 |
| 19 |
26271253 | Mice lacking prostaglandin E receptor subtype 4 manifest disrupted lipid metabolism attributable to impaired triglyceride clearance. | 2015 Dec |
1 |
| 20 |
24270984 | Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice. | 2014 Mar |
8 |
| 21 |
24437489 | FoxO6 integrates insulin signaling with MTP for regulating VLDL production in the liver. | 2014 Apr |
1 |
| 22 |
24548803 | FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model. | 2014 May |
1 |
| 23 |
24798233 | Mining the genome for lipid genes. | 2014 Oct |
1 |
| 24 |
22941940 | A role for hepatic leptin signaling in lipid metabolism via altered very low density lipoprotein composition and liver lipase activity in mice. | 2013 Feb |
3 |
| 25 |
23460782 | Acute central neuropeptide Y administration increases food intake but does not affect hepatic very low-density lipoprotein (VLDL) production in mice. | 2013 |
2 |
| 26 |
22488425 | Hepatic ABC transporters and triglyceride metabolism. | 2012 Jun |
2 |
| 27 |
22616721 | Effects of pyrazole partial agonists on HCA(2) -mediated flushing and VLDL-triglyceride levels in mice. | 2012 Oct |
2 |
| 28 |
23047827 | Triglyceride accumulation in macrophages upregulates paraoxonase 2 (PON2) expression via ROS-mediated JNK/c-Jun signaling pathway activation. | 2012 Nov-Dec |
3 |
| 29 |
23133675 | GLP-1 receptor activation inhibits VLDL production and reverses hepatic steatosis by decreasing hepatic lipogenesis in high-fat-fed APOE*3-Leiden mice. | 2012 |
1 |
| 30 |
21357939 | Hepatocyte-specific IKK-β activation enhances VLDL-triglyceride production in APOE*3-Leiden mice. | 2011 May |
1 |
| 31 |
21471511 | Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance. | 2011 May |
1 |
| 32 |
21750705 | VLDL hydrolysis by hepatic lipase regulates PPARδ transcriptional responses. | 2011 |
1 |
| 33 |
21810592 | Apolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor. | 2011 Sep |
1 |
| 34 |
21837751 | Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice. | 2011 Dec |
2 |
| 35 |
21862721 | Aspirin reduces hypertriglyceridemia by lowering VLDL-triglyceride production in mice fed a high-fat diet. | 2011 Dec |
2 |
| 36 |
22018640 | Eicosapentaenoic acid administration attenuates the pro-inflammatory properties of VLDL by decreasing its susceptibility to lipoprotein lipase in macrophages. | 2011 Dec |
4 |
| 37 |
22260066 | [Hyperlipidemia in hepatic MED1 deficient mice in response to fasting]. | 2011 Oct |
1 |
| 38 |
19723664 | Scavenger receptor BI facilitates hepatic very low density lipoprotein production in mice. | 2010 Mar |
1 |
| 39 |
20037162 | LXR-SREBP-1c-phospholipid transfer protein axis controls very low density lipoprotein (VLDL) particle size. | 2010 Feb 26 |
1 |
| 40 |
20124557 | A role of apolipoprotein D in triglyceride metabolism. | 2010 Jun |
1 |
| 41 |
20488800 | Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice. | 2010 Sep |
2 |
| 42 |
20501652 | Fenofibrate increases very low density lipoprotein triglyceride production despite reducing plasma triglyceride levels in APOE*3-Leiden.CETP mice. | 2010 Aug 13 |
9 |
| 43 |
20605947 | Ablation of the very-long-chain fatty acid elongase ELOVL3 in mice leads to constrained lipid storage and resistance to diet-induced obesity. | 2010 Nov |
1 |
| 44 |
20966404 | Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1. | 2010 Dec |
2 |
| 45 |
19147676 | Bexarotene induces dyslipidemia by increased very low-density lipoprotein production and cholesteryl ester transfer protein-mediated reduction of high-density lipoprotein. | 2009 May |
4 |
| 46 |
19187774 | Cideb, an ER- and lipid droplet-associated protein, mediates VLDL lipidation and maturation by interacting with apolipoprotein B. | 2009 Feb |
2 |
| 47 |
19273907 | Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. | 2009 Apr |
1 |
| 48 |
19287042 | Reduced insulin-mediated inhibition of VLDL secretion upon pharmacological activation of the liver X receptor in mice. | 2009 Jul |
7 |
| 49 |
19317061 | [Effects of very low-density lipoprotein on cellular lipid accumulation and the expression of monocyte chemoattractant protein-1 in human mesangial cells]. | 2009 Feb |
2 |
| 50 |
18056685 | Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice. | 2008 Mar |
1 |